Filing Flows

Filing Flows › Acadia Pharmaceuticals (ACAD) › Who owns the stock

Who owns Acadia Pharmaceuticals (ACAD) stock

333 funds reported Acadia Pharmaceuticals (ACAD) shares in their latest 13F filings, worth $4.6B in all. The largest holder is Baker Bros. Advisors LP ($1.1B). Last quarter 166 funds added to their stakes and 134 cut them.

Largest holders of ACAD (13F)Largest holders of ACAD (13F)Baker Bros. Advisors LP$1.1BBlackRock$570MVanguard Group$405MState Street$230MVanguard Portfolio Management LLC$224MRTW Investments, LP$181MVanguard Capital Management LLC$146MDimensional Fund Advisors LP$93.5MGeode Capital Management, LLC$85.0MPalo Alto Investors LP$72.5M

Largest holders (13F)

FundSharesValueChangeQuarter
Baker Bros. Advisors LP42,912,904$1.1Bincrease2026-06-30
BlackRock22,515,173$570Mincrease2026-06-30
Vanguard Group15,153,957$405Mdecrease2025-12-31
State Street9,076,212$230Mincrease2026-06-30
Vanguard Portfolio Management LLC8,838,450$224Mincrease2026-06-30
RTW Investments, LP7,144,524$181Munchanged2026-06-30
Vanguard Capital Management LLC5,763,750$146Mincrease2026-06-30
Dimensional Fund Advisors LP3,694,988$93.5Mincrease2026-06-30
Geode Capital Management, LLC3,358,129$85.0Mdecrease2026-06-30
Palo Alto Investors LP2,864,096$72.5Mdecrease2026-06-30
Goldman Sachs Group2,580,115$65.3Mincrease2026-06-30
Qube Research & Technologies2,446,610$61.9Mincrease2026-06-30
Point72 Asset Management, L.P.2,433,168$61.6Mdecrease2026-06-30
Citadel Advisors LLC2,182,177$55.2Mincrease2026-06-30
Pictet Asset Management Holding SA1,983,198$50.1Mdecrease2026-06-30

Acadia Pharmaceuticals' latest quarter

Acadia Pharmaceuticals, Q3 2026: revenue $342M (+23% year over year), operating margin 21.0%, net earnings $53.5M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most ACAD stock?

By the latest 13F filings: Baker Bros. Advisors LP ($1.1B); BlackRock ($570M); Vanguard Group ($405M); State Street ($230M); Vanguard Portfolio Management LLC ($224M).

What is the short interest in ACAD?

9,094,151 shares were sold short at the 2026-10-15 settlement, 9.89% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.